Please login to the form below

Not currently logged in

Metrics appoints director of pharma development

Promotion for Joseph Cobb at contract development and manufacturing organisation

Joseph Cobb has been named as the director of pharmaceutical development at the US contract development and manufacturing company Metrics.

The appointment is a promotion for Cobb, who has been with North Carolina-based Metrics since 2002, serving most recently as associate director of pharmaceutical development.

In his new role, Cobb will oversee Metrics' work in early-phase solid oral dosage development, as well as the company's potent and cytotoxic drug development services.

These services cover pharmaceutical formulation development; first-time- in-man formulations; and the manufacturing of clinical materials for trials covering phase I to III.

“Joe is a smart and capable leader who has been instrumental in guiding the success and growth of Metrics' formulation development capabilities,” said Phil Hodges, president of the company, which operates as a subsidiary of Mayne Pharma.

“With these new responsibilities, Joe will bring to his role the same thoughtfulness and resourcefulness.”

7th February 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

Haseeb Ahmad
Can value-based healthcare take off and reach for the skies?
Are companies willing to contribute to the change in the healthcare system?...
Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...